PROVIDER PROFILE · NPI 1770523227

Mark YoffeM.D.

PRACTICEREX HOSPITAL INCSee all providers at this practice →

Hematology-OncologyRaleigh, NCI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

Unique beneficiaries

—

Total services

Distinct HCPCS

Medicare payment

$5K

Peer benchmark

Total Medicare services vs. 329 Hematology-Oncology providers in NC — bottom quintile (cohort median 605).

PRESCRIBING · PART D · 2024

No data available for this provider in 2024.

QUALITY · MIPS · 2024

No data available for this provider in 2024.

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

No data available for this provider in 2024.

REFERRAL NETWORK

Where Mark Yoffe's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 26 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
REX HOSPITAL INC.	390	9,096
Henry Cromartie Internal Medicine · Raleigh, NC	80	435
Alan Kritz Hematology-Oncology · Raleigh, NC	80	587
SOLSTAS LAB PARTNERS GROUP LLC	35	290
Andrew Moran Diagnostic Radiology · Raleigh, NC	34	165
DUKE UNIVERSITY HEALTH SYSTEM INC	32	271
Laura Thomas Diagnostic Radiology · Raleigh, NC	27	104
John Alley Diagnostic Radiology · Raleigh, NC	25	152
Jerry Watson Diagnostic Radiology · Raleigh, NC	25	129
Kirk Peterson Diagnostic Radiology · Raleigh, NC	24	80
Julia Taber Diagnostic Radiology · Raleigh, NC	23	92
Gregory Bortoff Diagnostic Radiology · Raleigh, NC	21	102

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history